{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:02:36Z","timestamp":1790956956552,"version":"4.1.0"},"reference-count":113,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T00:00:00Z","timestamp":1610841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>It is 120\u2009years since \u2018angiomyositis\u2019 was included alongside \u2018polymyositis\u2019 and \u2018dermatomyositis\u2019 in an attempt to propose a taxonomy that reflected the major clinical characteristics of idiopathic inflammatory myopathy (IIM). Endothelial injury, perivascular inflammation and capillary loss are important histological findings in affected tissues in IIM. Overt vascular clinical features including RP and abnormal nailfold capillaroscopy (NC) are also common in IIM. Despite the presence of endothelial injury, perivascular inflammation and capillary loss in affected tissues in IIM, and the presence of clinical features such as RP and NC abnormalities, the pathogenic and therapeutic implications of vasculopathy in IIM have been somewhat overlooked. RP and NC abnormalities are not always present, providing a valuable opportunity to explore aetiopathogenic factors driving vasculopathy within autoimmune rheumatic disease. The present review examines the aetiopathogenic, prognostic and therapeutic significance of vasculopathy in IIM. We describe the prevalence and clinical relevance of vasculopathy in IIM, and consider how vasculopathy may be better utilized to support improved IIM diagnosis and disease classification. Areas of unmet research need are highlighted where relevant.<\/jats:p>","DOI":"10.1093\/rheumatology\/keaa816","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T02:45:30Z","timestamp":1606272330000},"page":"1593-1607","source":"Crossref","is-referenced-by-count":10,"title":["The aetiopathogenic significance, clinical relevance and therapeutic implications of vasculopathy in idiopathic inflammatory myopathy"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2793-2364","authenticated-orcid":false,"given":"John D","family":"Pauling","sequence":"first","affiliation":[{"name":"Royal National Hospital for Rheumatic Diseases (Part of the Royal United Hospitals NHS Foundation Trust), Bath, UK"},{"name":"Department of Pharmacy and Pharmacology, University of Bath, Bath, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Christopher-Stine","sequence":"additional","affiliation":[{"name":"Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,17]]},"reference":[{"key":"2021040620410326900_keaa816-B1","first-page":"426","article-title":"Polymyosite derinatomyosite; angiomyosite","volume":"21","author":"L\u00e9pine","year":"1901","journal-title":"Rev de Med Paris"},{"key":"2021040620410326900_keaa816-B2","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","article-title":"Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors","volume":"31","author":"Gasparyan","year":"2011","journal-title":"Rheumatol Int"},{"key":"2021040620410326900_keaa816-B3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/BOR.0000000000000442","article-title":"Cardiovascular involvement in myositis","volume":"29","author":"Diederichsen","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"2021040620410326900_keaa816-B4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s13075-014-0435-y","article-title":"A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases","volume":"16","author":"Lee","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2021040620410326900_keaa816-B5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/hrt.18.2.273","article-title":"Pulmonary hypertension in dermatomyositis","volume":"18","author":"Caldwell","year":"1956","journal-title":"Br Heart J"},{"key":"2021040620410326900_keaa816-B6","doi-asserted-by":"crossref","DOI":"10.4103\/injr.injr_136_20","article-title":"The clinicoserological spectrum of inflammatory myopathy in the context of systemic sclerosis and systemic lupus erythematosus","author":"Pauling","year":"2020","journal-title":"Indian J Rheumatol"},{"key":"2021040620410326900_keaa816-B7","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/acr.23475","article-title":"Multi-national qualitative research study exploring the patient experience of Raynaud's phenomenon in systemic sclerosis","volume":"70","author":"Pauling","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021040620410326900_keaa816-B8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/rheumatology\/key026","article-title":"The patient experience of Raynaud's phenomenon in systemic sclerosis","volume":"58","author":"Pauling","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2021040620410326900_keaa816-B9","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"2021040620410326900_keaa816-B10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/000155502753600894","article-title":"Dermatomyositis in 132 patients with different clinical subtypes: cutaneous signs, constitutional symptoms and circulating antibodies","volume":"82","author":"Parodi","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"2021040620410326900_keaa816-B11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0248-8663(05)82836-X","article-title":"Vascular manifestations of dermatomyositis and polymyositis. Clinical, capillaroscopic and histological aspects","volume":"15","author":"Leteurtre","year":"1994","journal-title":"Rev Med Interne"},{"key":"2021040620410326900_keaa816-B12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/rheumatology\/key257","article-title":"Significance of nailfold videocapillaroscopy in patients with idiopathic inflammatory myopathies","volume":"58","author":"Kubo","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2021040620410326900_keaa816-B13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/1756-185X.13456","article-title":"Raynaud's phenomenon and anti-nuclear antibody are associated with pulmonary function decline in patients with dermatomyositis and polymyositis","volume":"22","author":"Park","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"2021040620410326900_keaa816-B14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/BOR.0b013e32833f1987","article-title":"Clinically amyopathic dermatomyositis","volume":"22","author":"Sato","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"2021040620410326900_keaa816-B15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archderm.138.7.885","article-title":"Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients","volume":"138","author":"Sparsa","year":"2002","journal-title":"Arch Dermatol"},{"key":"2021040620410326900_keaa816-B16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease \u2013 an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am J Med"},{"key":"2021040620410326900_keaa816-B17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/03009747809095661","article-title":"Symptomatology and diagnosis in connective tissue disease. II. Evaluations and follow-up examinations in consequence of a speckled antinuclear immunofluorescence pattern","volume":"7","author":"Jonsson","year":"1978","journal-title":"Scand J Rheumatol"},{"key":"2021040620410326900_keaa816-B18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2009.09484.x","article-title":"Long-term outcome of patients with polymyositis\/dermatomyositis and anti-PM-Scl antibody","volume":"162","author":"Marie","year":"2010","journal-title":"Br J Dermatol"},{"key":"2021040620410326900_keaa816-B19","doi-asserted-by":"crossref","first-page":"e2068","DOI":"10.1212\/WNL.0000000000005638","article-title":"Muscular and extramuscular clinical features of patients with anti-PM\/Scl autoantibodies","volume":"90","author":"De Lorenzo","year":"2018","journal-title":"Neurology"},{"key":"2021040620410326900_keaa816-B20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00005792-199211000-00001","article-title":"The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl","volume":"71","author":"Marguerie","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"2021040620410326900_keaa816-B21","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/annrheumdis-2019-215046","article-title":"Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups","volume":"78","author":"Rothwell","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021040620410326900_keaa816-B22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1172\/JCI110295","article-title":"Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap","volume":"68","author":"Mimori","year":"1981","journal-title":"J Clin Invest"},{"key":"2021040620410326900_keaa816-B23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/annrheumdis-2018-214439","article-title":"Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes","volume":"78","author":"Spielmann","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021040620410326900_keaa816-B24","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-216375","article-title":"Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients","author":"Ogawa-Momohara","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021040620410326900_keaa816-B25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/acr.22163","article-title":"Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement","volume":"66","author":"Kaji","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021040620410326900_keaa816-B26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.autrev.2018.01.006","article-title":"Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype","volume":"17","author":"Fritzler","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2021040620410326900_keaa816-B27","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","article-title":"Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes","volume":"77","author":"Marguerie","year":"1990","journal-title":"Q J Med"},{"key":"2021040620410326900_keaa816-B28","doi-asserted-by":"crossref","DOI":"10.4103\/injr.injr_134_20","article-title":"An atypical presentation of antisynthetase syndrome","author":"Kapoor","year":"2020.","journal-title":"Indian J Rheumatol"},{"key":"2021040620410326900_keaa816-B29","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/rheumatology\/kex458","article-title":"Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1\/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis","volume":"57","author":"Pauling","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2021040620410326900_keaa816-B30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.autrev.2017.01.008","article-title":"Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: results from a multicenter, international and retrospective study","volume":"16","author":"Bartoloni","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2021040620410326900_keaa816-B31","first-page":"44","article-title":"Timing of onset affects arthritis presentation pattern in antisyntethase syndrome","volume":"36","author":"Gonzalez-Gay","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2021040620410326900_keaa816-B32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12016-016-8528-9","article-title":"Serum Jo-1 autoantibody and isolated arthritis in the antisynthetase syndrome: review of the literature and report of the experience of AENEAS Collaborative Group","volume":"52","author":"Cavagna","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"2021040620410326900_keaa816-B33","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1378\/chest.08-2233","article-title":"Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature","volume":"135","author":"Kalluri","year":"2009","journal-title":"Chest"},{"key":"2021040620410326900_keaa816-B34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejim.2013.01.002","article-title":"Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome","volume":"24","author":"Marie","year":"2013","journal-title":"Eur J Intern Med"},{"key":"2021040620410326900_keaa816-B35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/08916930600623767","article-title":"Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies","volume":"39","author":"Mielnik","year":"2006","journal-title":"Autoimmunity"},{"key":"2021040620410326900_keaa816-B36","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/art.22506","article-title":"Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase","volume":"56","author":"Hirakata","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021040620410326900_keaa816-B37","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/rheumatology\/kel435","article-title":"Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies","volume":"46","author":"Sato","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"2021040620410326900_keaa816-B38","first-page":"S326","article-title":"Cutaneous ulceration in dermatomyositis: association with MDA-5 and interstitial lung disease","volume":"64","author":"Narang","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2021040620410326900_keaa816-B39","doi-asserted-by":"crossref","first-page":"iii19","DOI":"10.1093\/rheumatology\/kep105","article-title":"Digital ulcers: overt vascular disease in systemic sclerosis","volume":"48","author":"Steen","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"2021040620410326900_keaa816-B40","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/acr.22498","article-title":"Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease","volume":"67","author":"Narang","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021040620410326900_keaa816-B41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study","volume":"65","author":"Fiorentino","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2021040620410326900_keaa816-B42","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1212\/WNL.0000000000009727","article-title":"Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases","volume":"95","author":"Allenbach","year":"2020","journal-title":"Neurology"},{"key":"2021040620410326900_keaa816-B43","article-title":"Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future","author":"Wang","year":"2020.","journal-title":"Ann Rheum Dis"},{"key":"2021040620410326900_keaa816-B44","doi-asserted-by":"crossref","first-page":"2001618","DOI":"10.1183\/13993003.01618-2020","article-title":"Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?","volume":"56","author":"Giannini","year":"2020","journal-title":"Eur Respir J"},{"key":"2021040620410326900_keaa816-B45","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/ard.2005.040717","article-title":"Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2\u03b2 antigen","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2021040620410326900_keaa816-B46","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/ard.2008.097162","article-title":"Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis","volume":"68","author":"Betteridge","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021040620410326900_keaa816-B47","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/acr.23210","article-title":"Cutaneous and systemic findings associated with nuclear matrix protein 2 antibodies in adult dermatomyositis patients","volume":"69","author":"Rogers","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021040620410326900_keaa816-B48","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaad.2014.12.009","article-title":"Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1\u03b3 antibodies in adults with dermatomyositis","volume":"72","author":"Fiorentino","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"2021040620410326900_keaa816-B49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MD.0b013e31827f264d","article-title":"The clinical phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"92","author":"Shah","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"2021040620410326900_keaa816-B50","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/acr.21753","article-title":"Comparison of children with onset of juvenile dermatomyositis symptoms before or after their fifth birthday in a UK and Ireland juvenile dermatomyositis cohort study","volume":"64","author":"Martin","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021040620410326900_keaa816-B51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","article-title":"The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"92","author":"Rider","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"2021040620410326900_keaa816-B52","first-page":"31","article-title":"Juvenile dermatomyositis: medical, social and economic status in adulthood","volume":"126","author":"Chalmers","year":"1982","journal-title":"Can Med Assoc J"},{"key":"2021040620410326900_keaa816-B53","first-page":"67","article-title":"Dermatomyositis: an association of gingival telangiectases and anti Jo-1 antibody in the adult","volume":"16","author":"Dourmishev","year":"2007","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"2021040620410326900_keaa816-B54","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s10067-018-04422-z","article-title":"Mechanic hands: clinical and capillaroscopy manifestations of patients with connective tissue diseases presented with and without mechanic hands","volume":"38","author":"Shenavandeh","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2021040620410326900_keaa816-B55","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamadermatol.2013.10416","article-title":"Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis","volume":"150","author":"Valenzuela","year":"2014","journal-title":"JAMA Dermatol"},{"key":"2021040620410326900_keaa816-B56","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.semarthrit.2018.02.005","article-title":"Does nailfold capillaroscopy help predict future outcomes in systemic sclerosis? A systematic literature review","volume":"48","author":"Paxton","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2021040620410326900_keaa816-B57","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3899\/jrheum.090697","article-title":"Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension","volume":"37","author":"Shah","year":"2010","journal-title":"J Rheumatol"},{"key":"2021040620410326900_keaa816-B58","doi-asserted-by":"crossref","first-page":"e4911","DOI":"10.1097\/MD.0000000000004911","article-title":"Pulmonary arterial hypertension in idiopathic inflammatory myopathies: data from the French pulmonary hypertension registry and review of the literature","volume":"95","author":"Sanges","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2021040620410326900_keaa816-B59","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.2008.103382","article-title":"Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis","volume":"69","author":"Allanore","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2021040620410326900_keaa816-B60","first-page":"1036","article-title":"Cardiometabolic risk and subclinical vascular damage assessment in idiopathic inflammatory myopathies: a challenge for the clinician","volume":"37","author":"Barsotti","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2021040620410326900_keaa816-B61","first-page":"82","article-title":"From VEDOSS to established systemic sclerosis diagnosis according to ACR\/EULAR 2013 classification criteria: a French-Italian capillaroscopic survey","volume":"36","author":"Vasile","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2021040620410326900_keaa816-B62","first-page":"1573","article-title":"Jr. Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"2021040620410326900_keaa816-B63","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/jid.1966.143","article-title":"Nail fold capillaroscopy\u2014a useful aid in the diagnosis of collagen vascular diseases","volume":"47","author":"Ross","year":"1966","journal-title":"J Invest Dermatol"},{"key":"2021040620410326900_keaa816-B64","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1007\/s10067-019-04710-2","article-title":"Nailfold videocapillaroscopy alterations in dermatomyositis, antisynthetase syndrome, overlap myositis, and immune-mediated necrotizing myopathy","volume":"38","author":"Soubrier","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2021040620410326900_keaa816-B65","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/art.1780310116","article-title":"Nailfold capillary microscopy in polymyositis and dermatomyositis","volume":"31","author":"Ganczarczyk","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2021040620410326900_keaa816-B66","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1468-3083.2004.00853.x","article-title":"Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud's disease","volume":"18","author":"Nagy","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2021040620410326900_keaa816-B67","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10067-014-2795-8","article-title":"Nailfold capillaroscopic changes in dermatomyositis and polymyositis","volume":"34","author":"Manfredi","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2021040620410326900_keaa816-B68","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3899\/jrheum.160122","article-title":"Nailfold videocapillaroscopy alterations in dermatomyositis and systemic sclerosis: toward identification of a specific pattern","volume":"43","author":"Manfredi","year":"2016","journal-title":"J Rheumatol"},{"key":"2021040620410326900_keaa816-B69","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.180355","article-title":"Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: results of a Multicenter International Study","volume":"46","author":"Sebastiani","year":"2019","journal-title":"J Rheumatol"},{"key":"2021040620410326900_keaa816-B70","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/art.1780250807","article-title":"Nailfold capillary abnormalities and clinical outcome in childhood dermatomyositis","volume":"25","author":"Spencer-Green","year":"1982","journal-title":"Arthritis Rheum"},{"key":"2021040620410326900_keaa816-B71","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/art.27379","article-title":"Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis","volume":"62","author":"Ostrowski","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2021040620410326900_keaa816-B72","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/art.39200","article-title":"Analysis of published criteria for clinically inactive disease in a large juvenile dermatomyositis cohort shows that skin disease is underestimated","volume":"67","author":"Almeida","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2021040620410326900_keaa816-B73","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/art.1780260919","article-title":"Serial changes in nailfold capillary morphology in childhood dermatomyositis","volume":"26","author":"Nussbaum","year":"1983","journal-title":"Arthritis Rheum"},{"key":"2021040620410326900_keaa816-B74","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/rheumatology\/keq051","article-title":"Quantitative nailfold video capillaroscopy in patients with idiopathic inflammatory myopathy","volume":"49","author":"Mercer","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2021040620410326900_keaa816-B75","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/diagnostics10050253","article-title":"Nailfold videocapillaroscopy is a useful tool to recognize definite forms of systemic sclerosis and idiopathic inflammatory myositis in interstitial lung disease patients","volume":"10","author":"Sambataro","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"2021040620410326900_keaa816-B76","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/03009740701640209","article-title":"Functional and morphological evaluation of hand microcirculation with nailfold capillaroscopy and laser Doppler imaging in Raynaud's and Sjogren's syndrome and poly\/dermatomyositis","volume":"37","author":"Szabo","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"2021040620410326900_keaa816-B77","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/kem175","article-title":"Microvascular responses following digital thermal hyperaemia and iontophoresis measured by laser Doppler imaging in idiopathic inflammatory myopathy","volume":"46","author":"Gunawardena","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"2021040620410326900_keaa816-B78","first-page":"1591","article-title":"Color Doppler ultrasonography of hand and finger arteries to differentiate primary from secondary forms of Raynaud's phenomenon","volume":"35","author":"Schmidt","year":"2008","journal-title":"J Rheumatol"},{"key":"2021040620410326900_keaa816-B79","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/art.1780250203","article-title":"Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis","volume":"25","author":"Crowe","year":"1982","journal-title":"Arthritis Rheum"},{"key":"2021040620410326900_keaa816-B80","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-4362.1990.tb04081.x","article-title":"Relationship between capillary and muscle damage in dermatomyositis","volume":"29","author":"Casademont","year":"1990","journal-title":"Int J Dermatol"},{"key":"2021040620410326900_keaa816-B81","first-page":"470","article-title":"Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis","volume":"55","author":"Gitiaux","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2021040620410326900_keaa816-B82","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/annrheumdis-2012-201822","article-title":"Whole microvascular unit deletions in dermatomyositis","volume":"72","author":"Gitiaux","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2021040620410326900_keaa816-B83","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13075-018-1569-0","article-title":"Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression","volume":"20","author":"Bosello","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2021040620410326900_keaa816-B84","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/0973-3698.219083","article-title":"The pathogenesis of scleroderma","volume":"12","author":"Gupta","year":"2017","journal-title":"Indian J Rheumatol"},{"key":"2021040620410326900_keaa816-B85","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.29.1.67","article-title":"Endothelial inclusions in dermatomyositis","volume":"29","author":"Norton","year":"1970","journal-title":"Ann Rheum Dis"},{"key":"2021040620410326900_keaa816-B86","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-3-2","article-title":"Endothelial cell activation and neovascularization are prominent in dermatomyositis","volume":"3","author":"Nagaraju","year":"2006","journal-title":"J Autoimmune Dis"},{"key":"2021040620410326900_keaa816-B87","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/rheumatology\/kew288","article-title":"Dysfunction of endothelial progenitor cells is associated with the type I IFN pathway in patients with polymyositis and dermatomyositis","volume":"55","author":"Ekholm","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2021040620410326900_keaa816-B88","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3899\/jrheum.181275","article-title":"Endothelial activation markers as disease activity and damage measures in juvenile dermatomyositis","volume":"47","author":"Kishi","year":"2020","journal-title":"J Rheumatol"},{"key":"2021040620410326900_keaa816-B89","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1600-0560.2006.00706.x","article-title":"Histopathology of Gottron's papules \u2013 utility in diagnosing dermatomyositis","volume":"34","author":"Mendese","year":"2007","journal-title":"J Cutan Pathol"},{"key":"2021040620410326900_keaa816-B90","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.23884","article-title":"Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis","volume":"58","author":"Grundtman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2021040620410326900_keaa816-B91","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2169\/internalmedicine.42.1233","article-title":"Dermatomyositis with peripheral nervous system involvement: activation of vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) in vasculitic lesions","volume":"42","author":"Matsui","year":"2003","journal-title":"Intern Med"},{"key":"2021040620410326900_keaa816-B92","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s10067-019-04537-x","article-title":"Nailfold capillary changes in adult new-onset dermatomyositis: a prospective cross-sectional study","volume":"38","author":"Miossi","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2021040620410326900_keaa816-B93","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s42358-018-0018-8","article-title":"Relevance of serum angiogenic cytokines in adult patients with dermatomyositis","volume":"58","author":"da Silva","year":"2018","journal-title":"Adv Rheumatol"},{"key":"2021040620410326900_keaa816-B94","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/srep01317","article-title":"Secreted Threonyl-tRNA synthetase stimulates endothelial cell migration and angiogenesis","volume":"3","author":"Williams","year":"2013","journal-title":"Sci Rep"},{"key":"2021040620410326900_keaa816-B95","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/0046-8177(92)90400-W","article-title":"Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy","volume":"23","author":"Estruch","year":"1992","journal-title":"Hum Pathol"},{"key":"2021040620410326900_keaa816-B96","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1365-4632.2009.04164.x","article-title":"A histopathologic study of mechanic's hands associated with dermatomyositis: a report of five cases","volume":"48","author":"Mii","year":"2009","journal-title":"Int J Dermatol"},{"key":"2021040620410326900_keaa816-B97","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3899\/jrheum.141443","article-title":"The prevalence of individual histopathologic features varies according to autoantibody status in muscle biopsies from patients with dermatomyositis","volume":"42","author":"Pinal-Fernandez","year":"2015","journal-title":"J Rheumatol"},{"key":"2021040620410326900_keaa816-B98","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/ene.14097","article-title":"Perimysial microarteriopathy in dermatomyositis with anti-nuclear matrix protein-2 antibodies","volume":"27","author":"Liu","year":"2020","journal-title":"Eur J Neurol"},{"key":"2021040620410326900_keaa816-B99","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/rheumatology\/kel025","article-title":"An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM)","volume":"45","author":"Brown","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"2021040620410326900_keaa816-B100","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/cei.12194","article-title":"Diagnosis, pathogenesis and treatment of myositis: recent advances","volume":"175","author":"Carstens","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"2021040620410326900_keaa816-B101","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fneur.2016.00064","article-title":"Idiopathic inflammatory myopathies: clinical approach and management","volume":"7","author":"Malik","year":"2016","journal-title":"Front Neurol"},{"key":"2021040620410326900_keaa816-B102","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrrheum.2018.42","article-title":"Treatment in myositis","volume":"14","author":"Oddis","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2021040620410326900_keaa816-B103","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2021040620410326900_keaa816-B104","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2021040620410326900_keaa816-B105","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2021040620410326900_keaa816-B106","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis & Rheumatism"},{"key":"2021040620410326900_keaa816-B107","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"key":"2021040620410326900_keaa816-B108","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1590\/S1806-37132011000100015","article-title":"Myositis-related interstitial lung disease and antisynthetase syndrome","volume":"37","author":"Solomon","year":"2011","journal-title":"J Bras Pneumol"},{"key":"2021040620410326900_keaa816-B109","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"2021040620410326900_keaa816-B110","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.10775","article-title":"Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement","volume":"48","author":"Steen","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2021040620410326900_keaa816-B111","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/acr.22520","article-title":"Traditional cardiovascular risk factors and coronary artery calcification in adults with polymyositis and dermatomyositis: a Danish multicenter study","volume":"67","author":"Diederichsen","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021040620410326900_keaa816-B112","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/ard.50.11.800","article-title":"A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases","volume":"50","author":"Torley","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"2021040620410326900_keaa816-B113","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jid.2016.03.001","article-title":"Identification of alpha-adrenergic agonists as potential therapeutic agents for dermatomyositis through drug-repurposing using public expression datasets","volume":"136","author":"Cho","year":"2016","journal-title":"J Invest Dermatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/4\/1593\/36913289\/keaa816.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/4\/1593\/36913289\/keaa816.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T23:46:58Z","timestamp":1617752818000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/4\/1593\/6103235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,17]]},"references-count":113,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,1,17]]},"published-print":{"date-parts":[[2021,4,6]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa816","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2021,1,17]]}}}